GlassScriptPhysician profile
Michelle E Ruszkiewicz
NPI 1801220470
$1,414.29
in general payments reported to CMS, 2019-2025
22 companies · $307 in 2025
The $307 reported for 2025 was more than what 75% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $158 · 2022: $253 · 2023: $223 · 2024: $474 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $905 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $904.99 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $236.58 | 2022-2025 | |
| Astellas Pharma US INC | $170.78 | 2023-2024 | Veozah, Myrbetriq |
| Abbvie INC. | $132.90 | 2021-2025 | |
| Agile Therapeutics, INC. | $104.91 | 2021-2023 | Twirla |
| Exeltis, USA INC. | $91.22 | 2021-2025 | Slynd |
| Coopersurgical, INC. | $87.45 | 2022-2025 | Paragard T 380a |
| Organon LLC | $84.68 | 2021-2024 | Nexplanon |
| Biogen, INC. | $77.94 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $77.81 | 2022-2025 | |
| Shield Therapeutics INC | $50.82 | 2023-2025 | Accrufer |
| Exact Sciences Corporation | $46.36 | 2023 | Cologuard Collection Kit |
| Aspira Women'S Health INC | $43.67 | 2024 | Ova1 |
| Hologic Sales and Service, LLC | $37.65 | 2024-2025 | Aptima |
| Ardelyx, INC. | $28.40 | 2024 | Ibsrela |
| Mylan Pharmaceuticals INC. | $23.79 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $20.41 | 2024 | Injectafer |
| Millicent US INC | $20.06 | 2024 | Intrarosa |
| Evofem Biosciences, INC. | $19.11 | 2021 | |
| Convatec INC. | $16.89 | 2025 | |
| Therapeuticsmd, INC. | $15.18 | 2022 | |
| Lupin INC. | $14.90 | 2021 | |
| Avanos Medical | $12.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Ruszkiewicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.